** JPM PACIFIC EQUITY C (DIST) USD | 11/03 | 8,55% |
| * JPM PACIFIC EQUITY D (ACC) EUR | 11/03 | 8,00% |
| * JPM PACIFIC EQUITY D (ACC) USD | 11/03 | 8,24% |
| ** JPM PACIFIC EQUITY I2 (ACC) EUR | 11/03 | 8,40% |
| ** JPM PACIFIC EQUITY I2 (ACC) USD | 11/03 | 8,62% |
| ** JPM PACIFIC EQUITY I (ACC) USD | 11/03 | 8,55% |
| *** JPM SGD LIQUIDITY LVNAV AGENCY (DIST) | 06/03 | 1,99% |
| ***** JPM SGD LIQUIDITY LVNAV C (ACC) | 06/03 | 2,21% |
| *** JPM SGD LIQUIDITY LVNAV C (DIST) | 06/03 | 1,99% |
| ND JPM SGD LIQUIDITY LVNAV E (ACC) | 06/03 | 2,23% |
| ND JPM SGD LIQUIDITY LVNAV E (DIST) | 06/03 | 1,99% |
| *** JPM SGD LIQUIDITY LVNAV INSTITUTIONAL (DIST) | 06/03 | 1,99% |
| ***** JPM TAIWAN A (ACC) EUR | 11/03 | 17,54% |
| ***** JPM TAIWAN A (ACC) USD | 11/03 | 17,76% |
| ***** JPM TAIWAN A (DIST) USD | 11/03 | 17,78% |
| ***** JPM TAIWAN C (ACC) USD | 11/03 | 17,96% |
| ***** JPM TAIWAN C (DIST) USD | 11/03 | 17,96% |
| ***** JPM TAIWAN D (ACC) USD | 11/03 | 17,54% |
| ***** JPM TAIWAN I (ACC) EUR | 11/03 | 17,74% |
| ***** JPM TAIWAN I (ACC) USD | 11/03 | 17,96% |
| ** JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | 11/03 | 5,69% |
| ** JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | 11/03 | 2,84% |
| * JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | 11/03 | 4,65% |
| ** JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | 11/03 | 5,70% |
| ** JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | 11/03 | 2,85% |
| * JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | 11/03 | 4,65% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | 11/03 | 5,81% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | 11/03 | 2,96% |
| * JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | 11/03 | 4,77% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | 11/03 | 5,82% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | 11/03 | 2,95% |
| * JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | 11/03 | 4,77% |
| ** JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | 11/03 | 2,92% |
| * JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | 11/03 | 4,74% |
| * JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | 11/03 | 4,73% |
| ** JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | 11/03 | 2,66% |
| * JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | 11/03 | 4,46% |
| ** JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | 11/03 | 2,96% |
| * JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | 11/03 | 4,77% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | 11/03 | 4,55% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | 11/03 | 2,95% |
| **** JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | 11/03 | 6,73% |
| **** JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | 11/03 | 6,94% |
| ** JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | 11/03 | 6,72% |
| * JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | 11/03 | 5,25% |
| **** JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | 11/03 | 6,89% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | 11/03 | 6,59% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | 11/03 | 6,81% |
| * JPM TOTAL EMERGING MARKETS INCOME D (DIV) EUR | 11/03 | 5,10% |
| *** JPM TOTAL EMERGING MARKETS INCOME I2 (ACC) EUR (HEDGED) | 11/03 | 5,20% |
